AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
In our latest Clinician’s View, Dr. Patel shares his team’s journey toward improving global health access, outcomes and equity through telesurgery, including how they are ensuring the safety, quality...
In our latest clinician’s view, Dr. Lopez shares how he, along with a multidisciplinary clinical team, were able to plan for this complex case and completely remove the tumor surgically, allowing...
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
Mortality rates from treatment-resistant pathogens continue to rise, and the culprits include a wide and growing range of mycobacteria and fungi.
As a former clinically practicing physician who now...
In our latest Clinician’s View, Dr. Lopez shares why his team recently became among the first in the country to begin using innovative technologies like near-infrared autofluorescence (NIRAF)...
Thoracic surgeon Colleen Gaughan, MD, and her team at AdventHealth Celebration, recently became one of the first in the country to incorporate targeted imaging agent Cytalux (pafolacianine) as part of...
AdventHealth recently began piloting a new Genomics Risk Assessment for Cancer and Early Detection (GRACE) program that combines the use of digital mammography, artificial intelligence (AI) technology...
AdventHealth Celebration recently became the first hospital in Florida to use DoseRT® Cherenkov imaging plus AlignRT® technology and the first hospital globally to use the entire surface guided...